Theodore, D. A., Henneman, A. D., Loo, A., Shields, R. K., Eschenauer, G., Sobieszczyk, M. E., & Kubin, C. J. (2024). Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia. Journal of Antimicrobial Chemotherapy, 79(8), 1877–1884. https://doi.org/10.1093/jac/dkae175
Subjects:
Micafungin
(MeSH)
Antifungal Agents
(MeSH)
Critical Illness
(MeSH)
Immunocompromised Host
(MeSH)
Candidemia
(MeSH)
Fluconazole
(MeSH)
Echinocandins
(MeSH)
Publication Type:
Article
Unique ID:
10.1093/jac/dkae175
PMID:
DOI:
Publication Date:
Data Source:
PubMed